BridgeMD
New treatment option for Irritable Bowel Syndrome
Official title Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children
ClinicalTrials.gov ID: NCT05730491
What this study is testing
- What it's testing
- The goal of this clinical trial is to test efficacy of the REACH program in parents with irritable bowel syndrome (IBS) and their young children. The main question it aims to answer is: -How can parents with IBS help their young kids develop healthy habits?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- for parents and their children (including biological/step-parents or legal guardians):
- Parent/caregiver at least 18 years old
- Parent diagnosed with IBS or idiopathic abdominal pain in the last five years OR
- Parent meets ROME criteria for IBS (abdominal pain at least weekly; pain related to defecation, change in stool frequency, and change in stool form...
- Is the parent primarily responsible for caring for the child on a day-to-day basis
You likely can't join if
- for parents and their children:
- Not able to read/speak/understand English.
- Child has a developmental disability that requires full-time special education
- Child has chronic abdominal pain (pain most/every day for more than 3 months)
- Child has a current doctor's diagnosis of a painful\ gastrointestinal disorder like functional constipation, lactose/fructose/gluten intolerance...
- Child has another severe chronic disease such as juvenile arthritis, cancer, or other severe condition(s) requiring chronic medical treatment.
See the full eligibility criteria
- for parents and their children (including biological/step-parents or legal guardians):
- Parent/caregiver at least 18 years old
- Parent diagnosed with IBS or idiopathic abdominal pain in the last five years OR
- Parent meets ROME criteria for IBS (abdominal pain at least weekly; pain related to defecation, change in stool frequency, and change in stool form at least 30% of the time)
- Is the parent primarily responsible for caring for the child on a day-to-day basis
- Child is 4 to 7 years old at the time of screening. If multiple children are present in the family, the parent will be asked to select one child for study participation.
- Child must currently live at least half of the time with the parent involved in intervention.
- Parent and child must reside in the U.S.
- for parents and their children:
- Not able to read/speak/understand English.
- Child has a developmental disability that requires full-time special education
- Child has chronic abdominal pain (pain most/every day for more than 3 months)
- Child has a current doctor's diagnosis of a painful\ gastrointestinal disorder like functional constipation, lactose/fructose/gluten intolerance, celiac disease, Inflammatory Bowel Disorder, etc. (\ does not include...
- Child has another severe chronic disease such as juvenile arthritis, cancer, or other severe condition(s) requiring chronic medical treatment.
- Does not have regular access to the Internet on a desktop, tablet, phone, or laptop computer
The study team makes the final eligibility decision.
Where it's taking place
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seattle, Washington, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.